BioCardia, Inc. (BCDA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-15

BioCardia, Inc. (BCDA) has filed 22 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-15. 10 Form 8-K material event filings were reported by BCDA in the last 90 days. InsiderAlpha tracks every BCDA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About BioCardia, Inc. (BCDA)

SIC classificationBiological Products, (No Diagnostic Substances) (SIC 2836)
SEC CIK0000925741

90-Day SEC Filing Activity

Form 4 filings (90d)22
Form 8-K filings (90d)10
Latest Form 4 filing2026-07-15

Recent BCDA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Altman PeterPresident and CEOP — Open-market purchase1.5K$0.86$1KSEC
Altman PeterPresident and CEOP — Open-market purchase2.8K$0.88$2KSEC
Altman PeterPresident and CEOP — Open-market purchase1.0K$0.94$940SEC
Altman PeterPresident and CEOP — Open-market purchase1.0K$0.90$900SEC
Altman PeterPresident and CEOP — Open-market purchase5.5K$0.97$5KSEC
Altman PeterPresident and CEOF — Tax withholding / forfeiture54.6K$1.24$68KSEC
GILLIS EDWARD MSenior Vice President, DevicesF — Tax withholding / forfeiture17.3K$1.24$21KSEC
McClung DavidChief Financial OfficerF — Tax withholding / forfeiture23.1K$1.24$29KSEC
McClung DavidChief Financial OfficerA — Grant or award60.5K$1.20$73KSEC
GILLIS EDWARD MSenior Vice President, DevicesA — Grant or award39.5K$1.20$47KSEC
Altman PeterPresident and CEOA — Grant or award110.6K$1.20$133KSEC
STERTZER SIMON HDirectorP — Open-market purchase39.0K$1.00$39KSEC
STERTZER SIMON HDirectorP — Open-market purchase70.2K$0.92$65KSEC
Altman PeterPresident and CEOP — Open-market purchase800$0.96$768SEC
Altman PeterPresident and CEOP — Open-market purchase1.5K$0.85$1KSEC

All transactions sourced from SEC EDGAR Form 4 filings for BioCardia, Inc. (BCDA). Updated in real time as new filings are submitted to the SEC.

Most-Active BCDA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Altman Peter18$236K
STERTZER SIMON H3$104K
McClung David3$101K
GILLIS EDWARD M3$69K
Allen Jim L.1—

Recent BCDA Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BCDA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

BCDA Insider Trading — FAQ

What is the latest insider trade for BCDA?
BioCardia, Inc. (BCDA) had 22 insider filings in the last 90 days, with the most recent on 2026-07-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying BCDA stock?
0 insider purchases of BCDA were filed in the last 90 days.
How many insiders are selling BCDA stock?
0 insider sales of BCDA were filed in the last 90 days.
Where can I see BCDA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every BCDA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live BCDA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.